The Collaborative Institutional Training Initiative (CITI) was founded in March 2000 to develop a web based training program in human research subjects protections. It has grown to include several hundred participating institutions from around the world.
You will need to select a learner group. See the table below for guidance on which learner groups you will need to select.
| Group 1 | FDA regulated research: investigational drugs, devices, and biologics. This learner group must also complete the Good Clinical Practice module. |
| Group 2 | Non-FDA regulated research: prevention/intervention studies, community-based studies, investigator-initiated studies that do not involve the use of investigational drugs, devices, or biologics. This learner group may also require completion of the Good Clinical Practice module. |
| Group 3 | Human derived materials research: specimens, human tissue, genetic/reproductive material, medical records, databanks, and registries. This learner group may also require completion of the Good Clinical Practice module. |
| Group 7 | Social and behavioral research: surveys, questionnaires, interviews, photography, tape recordings. This learner group may also require completion of the Good Clinical Practice module. |
| GCP | Good Clinical Practice |
Contact Information
If an investigator identifies a research team member who has requested accommodations for completing CITI modules, the investigator or the research team member should contact the IRB Office at 706-721-3110. The IRB Training Coordinator will work with the research team member to complete CITI under the needed, documented accommodations. The investigator should not be involved in applying the accommodations needed. (This includes but is not limited to entering answers for the individual, giving answers to the individual, taking the CITI modules for the individual, etc.). If you have any questions regarding accommodations, please contact the IRB Office at 706-721-3110.
